Calypte und die Zeit nach AIDS2004 in Bangkok

bin ich eigentlich immer ehrlich und kann auch fehler eingestehen. das ist genau der punkt an dem du fürchterlich uneinsichtig und stur bist.

mit meinen sogenannten "provokationen" habe ich hier schon viele leute vor weiterem investment bewahrt. nein - natürlich nicht euch hardliner...ihr seid eh nicht mehr zu retten. meinen eigenen thread brauche ich nicht. es reicht mir, wenn ich euer schöngerede und eure schönfärberei geraderücken kann...muahahahaha  

Bin neu hier,eure Kommentare lese ich seit einiger Zeit sehr aufmerksam.
Da ich mal aus einer Laune heraus in caly eingestiegen bin.
Und bis heute noch auf ein Wunder warte.  

eingestehen ?! Was hast du eigentlich für ein Problem ?!

Nochmals an Dich:

Kümmere Dich einfach um deinen eigenen Schrott, und verdrecke hier nicht sämtliche Informationen mit deinen Provokativen immer gleich lautenden Phrasen !

Mach dir deinen eigenen Thread auf ! Aber du weißt ja ganz genau, dass deinen Schrott dort niemand lesen würde.  

 

doch kade, das musst du...du tust es nur nicht und das ist das schlimme daran

wir haben uns schon darüber "unterhalten", als caly noch bei 0,96€ stand...damala, lange nach dem hype, der euch bis heute bei der stange gehalten hat...

sogenannte "sämtliche informationen" sind nichts anderes als ablenkungsmanöver, um euch zu suggerieren, dass hier was kommt. wenn caly jetzt noch seine tests bringt, sind sie locker die nummer so-und-soviél am markt. das ist ganz entscheidend.

du kannst aber gerne investiert bleiben, hauptsache andere sind klüger und ziehen irgendwann einmal die notbremse  

"du kannst aber gerne investiert bleiben"

und jetzt tschüss- darfst wieder zurück in den w.o.-augrid-pleite-Thread.  

fehlinvestment...du eben nicht. du würdest das wohl auch nie tun...  

 

Green Stars for Kade Mods




POST FROM YAHOO: CALYPTE JOBS ADVERTISED IN CHINA

jobs in China...
by: runcaly (49/M/de)
Long-Term Sentiment: Strong Buy 02/25/05 10:11 am
Msg: 2796 of 2806

http://ad.chinahr.com/...ontractID=20050128005988&single_service_id=4 2237

Translated:

Manager HR human affairs (1 person)

MFG makes manager (1 person)

QA guarantees manager (1 person)

The QC nature controls manager (1 person)

Invites QA, QC, HR and makes manager (each 1) (4 people)

Http://www.calypte.com
>>> Calypte biomedical corp. :::::::::::::::::::::::::::

The company introduces
American Calypte Corporation, soon sets up in the Beijing, China makes the factory, mainly produces in vitro diagnosis reagent (Rapid test) series product. The high salary honestly invites to have in vitro diagnosis class product production, the quality guaranteed that, correlation experience the and so on quality control outstanding talented person allies.

Contact method

Email:Zhaopin2008@sohu.com

Retrieval newest employment advertise information China person with outstanding ability net main page

Fantastic !
First posting by Kade in Ariva.de Germany
 

http://www1.zhaopin.com/PagesPublish/view.do?id=12097146

Translation:

Employment advertise position QA Manager Manager QC makes manager human resources manager The company introduces American Calypte Corporation, soon sets up in the Beijing, China makes the factory, mainly produces in vitro diagnosis reagent (Rapid test) series product. The high salary honestly invites to have in vitro diagnosis class product production, the quality guaranteed that, correlation experience the and so on quality control outstanding talented person allies. The details please consult: Www.calypte.com The wisdom association employment advertise network all rights reserved this network all employment advertise information and the work, have not had to reprint after the written authorization


 

Von einer der größten öffentlichen AIDS-Seiten in China !
Weshalb Calypte-Urine-Rapid-Tsts sinnvoller als die bisherigen Blood-Tests sind... Die Preise werden vom Autor mit 6 $ in China als günstig bezeichnet !!! 6 $  pro Test !!!

http://www.120d.com/printpage.asp?ArticleID=123

关于艾滋病尿检试纸
作者：120m    转贴自：本站原创    点击数：3440

尿检试纸不推荐个人使用,以下内容比较客观的说明问题,希望您能从中找到答案,以后任何关于血检和尿检的问题限于人力有限,请不要再向我们咨询,谢谢!

关于爱滋病尿检试纸：

首先在美国研究成功，由于不需要采血，方便,成本低在刚研制成功时很受新闻媒体青睐，相关报道在过去的２年也比较多（现在已经很少），但截止目前为止，其仍只能检测出1型爱滋病(爱滋病分1型和2型),国内目前为止暂时还没有研制成功任何爱滋病尿检试纸,目前各大医院防疫站也都是采用血液检测爱滋病(国内还没有哪家医院通过尿液检测爱滋病)

稍有英文基础的朋友可浏览全球唯一尿液检测试纸生产商美国卡里普特公司网站http://www.calypte.com/ 该公司的尿液检测试纸描述的为HIV-1型而不是HIV(1+2)型,国家已经明确下文件要求艾滋病初检必须使用HIV(1+2)型试剂,这也是其几年来得不到大面积推广的根本原因.

我们已经和美国卡里普特公司中国总代理北京中洋普特公司取得了联系,相关人士称个人自助使用的HIV(1+2)尿检试剂正在研发中,一旦产品成熟上市,本站会及时以公益的价格推荐给大家(尿检试剂成本比血检试剂成本低,最终零售价不到6美元),请时刻关注本站动态!

目前市面上的HIV-1尿检试剂必需在严格的实验室环境下经专业人员仪器操作并且添加多种试剂才可以得出正确的检测结果，否则会出现大量的阳性结果，从而给您的身心带来巨大的创伤．

关于血检试纸安全性:

有些朋友在来信中和电话中提到，试纸的安全性如何？即，试纸使用双抗原夹心法，有没有传染性？ 随着使用试纸检测者日益增多，提这种问题的朋友已经很少了，但我们觉得还是有必要把这个问题解释清楚，希望对此关心的网友看了以后能够明白。
试纸条上包被的抗原，并不是具有传染性的HIV病原体，也不是从HIV病原体中提取的物质成分，而是人工合成的一种高分子化合物，它只是在显微形态上具有与HIV抗原相似的抗原构像，所以能用来检测血液中的HIV抗体，而其本身根本无传染性可言.

为什么有些报道说血检危险:

这种危险性是相对于在医院给患者检测的医务检测者的,他们由于经常为大量人群采血检测,接触到的检测者的血液是危险的,由于职业暴露因素,医务人员也是爱滋病的高危人群,试剂本身无危险性和传染性,有危险性的是检测者的血液,血检的方式查爱滋病可能存在爱滋病患者传染医务人员的危险性,自助式的自己给自己检测是不存在任何传染的问题.

Hier die Übersetzung per Sotware:

Examines the indicator paper about the AIDS urine
Author: The 120m      
The urine examines the indicator paper not to recommend individual use, following content quite objective showing question, hoped you can find the answer, later any will examine the question about the blood which will examine with the urine to be restricted in the manpower to be limited, please will not have again to consult to us, thanks!
Examines the indicator paper about the AIDS urine:
First studies in US successfully, because does not need to pick the blood, convenient, the cost low when just was developing successfully received the news media favour very much, the related report quite many (now already very are also few) in the past 2 years, but the closure at present up to, it still only could examine 1AIDS(AIDS to divide 1 and 2), domestic up to temporarily has not at present developed successfully any AIDS urine to examine the indicator paper, (which hospital at present was each big hospital epidemic-prevention station also all domestically uses the blood examination AIDS not to have through urine examination AIDS)
Slightly has English foundation the friend may glance overglobal only urine examination indicator paper producer US Cary pood company websitehttp://www.calypte.com/ this company the urine examination indicator paper description is HIV-1 but is not HIV (1+2) under, the country already was clear about the document request at the beginning of AIDS to examine must use HIV (1+2) the reagent, this also was its for several years cannot obtain the big area promotion the basic reason
We the ocean pood company have already obtained the relation with American Cary pood company China general agent Beijing in, the related public figure called individual self-service use HIV (1+2) the urine examines the reagent to research and develop, once the product maturely goes on the market, the home station can promptly recommend by the public welfare price for everybody (urine examines reagent cost to examine reagent cost blood to be lower than, final retail price to 6 US dollars), does not invite the time to pay attention to the home station tendency!
At present in the market condition HIV-1 urine examines the reagentto have only then may obtain the correct examination result under the strict laboratory environment after the specialist instrument operation and the increase many kinds of reagents, otherwise can appear the massive masculine result, thus brings the huge wound for yours body and mind.
Examines the indicator paper security about the blood:
Some friends mentioned in the incoming letter and the telephone, indicator paper security how? Namely, the indicator paper uses the double antigen to contain filling the law, has the infection? Increased day by day along with the use indicator paper examination, the friend which asked this kind of question very much has already been short, but we thought or have the necessity to be clear this question explanation, hoped regarding this cared about 网友 will look at later to be able to understand.
Tries on the paper 包被 the antigen, certainly has the infectious HIV pathogen, also is not the material ingredient which withdraws from the HIV pathogen, but is the manual synthesis one kind of high-molecular compound, it only is has in the micro shape with the HIV antigen similar antigen conformation, therefore can use for to examine in the blood the HIV immune body, but its itself basic does not have the infection to be possible to say
Why some reports said the blood examines the danger:
This risk is opposite to in the hospital the medical examination which examines to the patient, they because frequently pick the blood examination for the massive crowds, contacts the examination blood is dangerous, as a result of the occupation exposition factor, the medical personnel also is the AIDS high danger crowd, reagent itself does not have the risk and the infection, has riskily is the examination blood, the way which the blood examines looks up the AIDS possibly to havethe AIDSpatient to infect medical personnel's risk, self-service -like own examines for oneself is does not have any infection the question.


Bitte in Ami-Boards verbreiten ! Wer von euch ist vincentkuba ?! Danke vorab !



 

 

Hallo, ich schaue mir dieses Forum schon laenger an, in welchem es ja um Calypte geht.
Tag fuer Tag gibt es hier nur Streit - vielleicht gehoert das ja dazu.
Ich freue mich jedenfalls auch ueber die letzten News :).
Es ist doch jedem klar, dass unsere Investitionen ein grosses Risiko haben - niemand
wuerde sich beschweren, wenn er alles verliert.
Auf eine totsichere Sache zu setzen ist doch keine Kunst, da gibt es ja auch nichts zu
gewinnen.
Auch wenn es vielleicht nicht sofort diese/naechste Woche losgeht, ich bin ueberzeugt,
dass wir mit Caly richtig Glueck haben.
Und fuer die Pessimisten: wenn nicht, dann ist das Geld halt weg - das wussten wir doch
schon vorher.

:)  

By: roy_hinkley  
26 Feb 2005, 07:43 PM EST
Msg. 66148 of 66169
Jump to msg. #  
Newsday Tuesday???

Time for a PR. HIV needs something to cover up the extremely poor results the 10K will show.

I predict that since the time is here, we will get a "double combo" whammy to overshadow the facts in the 10K.

1. Good tests results from Chinese tests
2. Another round of financing by Marr.

What you won't get in PR is the cost to produce Chinese tests and what they will sell for. Also non existent or buried will be how long it will take for approval, time to get ready for manufacture, and the mention that 49% of any profit that goes automatically to Marr.

You will also have to wait for the 8K filing to find out about the "terms and conditions" of this latest infusion of Marr cash.

Has to be done soon to comply with SEC rules plus the fact that the latest 2 million by Marr runs out on April Fools day.

If Marr puts up over 8 million, Tony Cataldo's contract is advanced so that he will receive concurrent with the financing, over 90 % of the 1 million golden parachute that Marr gave him before assigning him to MUCL.

"These guys are good".

 

Muahahahahahahah  

Thanks sower !!!

China info from 424B3 part 1
by: sowerharvest
Long-Term Sentiment: Strong Buy  02/28/05 02:39 pm


I put together information out of a CC and the latest 424B3 filing that relates to China. It's in the form of an interview. I made it that way because it is easier to read and is more concise than the filing. If you want to check the context just refer to the page number below each paragraph. You should refer to the 424B3 filing to see all of the risks related to each subject mentioned here.

How does an American company obtain regulatory approval in China?
In China, regulatory approval for a product is granted only for products manufactured in China and only to the Chinese manufacturer of such product. As a result, for us to maintain control of our products in China, we plan to manufacture our products in China through a joint venture involving BTBP.
Page 55

Who is BTBP?
BTBP is a biotech company that manufactures multiple vaccines for both viral and bacterial infections. The National Vaccine & Serum Institute of the Peoples' Republic of China currently owns approximately 66% of BTBP's outstanding shares.
Page 45

How are you planning to penetrate the Chinese market?
We believe that the key to our penetration of the Chinese market will hinge on the success of the Beijing Calypte Joint Venture with Marr Technologies Limited in obtaining regulatory approval for and manufacturing and marketing our rapid HIV test products in China.
Page 61

What are the details of this agreement?
In November, 2003, we became the 51% owner of a joint venture, Beijing Calypte Biomedical Technology Ltd. (the "Beijing Calypte Joint Venture"), created to market existing and potential new products in the People's Republic of China ("China"). The remaining 49% of the joint venture is owned by Marr Technologies Limited, an affiliate of Marr Technologies BV ("Marr"), our largest stockholder, with a security ownership of approximately 27% of our outstanding stock as of December 16, 2004.
Page 41

What progress have you made in China to begin regulatory approval of your products?
On December 1, 2004, we announced that we had commenced a clinical trial program for our rapid HIV-1/2 test platform and our HIV-1 Western blot supplemental tests in The People's Republic of China. The trial will evaluate the sensitivity and specificity of our three rapid HIV-1/2 Antibody Tests; Blood, Oral Fluid and Urine. The trial will also evaluate the Company's HIV-1 Western Blot supplemental tests in Blood and Urine. We plan to test approximately 1,500 patients using no less than 7 locations that will perform the rapid HIV ½ tests and using at least 3 laboratories that will perform the HIV-1 Western Blot supplemental tests. We expect to complete the data collection by the end of this year and have a full statistical analysis available approximately two weeks after the last patient has been enrolled. We will release the performance results when the trials have been completed and certified by our Chinese contractor. Our objective is to file the required regulatory applications with the Chinese FDA (SFDA) in early 2005.
Page 81

How and where did you manufacture the product for the clinical trials?
… BTBP has made facilities available to us to manufacture the rapid test products required for clinical trials in China.
Page 45

 

Thanks sower !!!

China info from 424B3 part 2
by: sowerharvest
Long-Term Sentiment: Strong Buy  02/28/05 02:40 pm


I put together information out of a CC and the latest 424B3 filing that relates to China. It's in the form of an interview. I made it that way because it is easier to read and is more concise than the filing. If you want to check the context just refer to the page number below each paragraph. You should refer to the 424B3 filing to see all of the risks related to each subject mentioned here.

What details can you give us in terms of your full scale manufacturing plant in China?
CC 10/28/2004 (Dr. George)
“…We have already started to select our staff; we will start the training in advance of the time when we get approval. Once we have completed the clinical trials in China, you know, once we see what the results of this clinical trials are we’re going to know that approval is either going to be coming or it’s not going to be coming, cause we know what we have to achieve, in terms of performance. So, again this is all planed to be done concurrently with everything coming together before the time when we have the ability to start selling in China. If we can get the process done earlier, we might consider some exportation from that facility.”

What are your prospects for sales in China?
Early indications, based on meetings with Chinese authorities in which both we and representatives of our joint venture partner participated, lead us to expect that there is great potential for revenues from the sale of rapid HIV tests in China.
Page 61

What is the size of the market there?
From the CC 10/28/2004 (Dr George)
“… You know, the size of that market is really mind boggling. Because, China has such a – they have a significant and a serious problem with the spread of HIV in their population and China has now recognized the seriousness of that threat to their population and have recognized that if it is not addressed very quickly ant appropriately that it could actually begin to affect the economic growth that they have experienced in the last few years. Just to put it a little bit in perspective; sex workers in China; there are approximately 30 million of them that are known registered sex workers. The Chinese government tests those people every quarter. So, if you just do the math; four times 30 million that’s 120 million tests per year, just for that one small segment of the Chinese population. China has recently made the offer to their people, that, they will give a free AIDS test to anyone who request it. There are 1.3 billion people in China. I don’t mean to suggest that all 1.3 billion people are lined up for an HIV test, but someone who is administering that program in China and at the CDC, he said, about 600 million tests this year in the program and remember people who need testing for HIV don’t test one time. It’s a recurring need because people, being what they are, find out they’re negative and they see that as encouragement to continue to behave in the old ways. I think you get a sense, it’s a huge market. I think we have some good products for that market.”

 

muhahahahahahahahahaha!!!!!!  

Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy

 

Sie haben geschrieben bis zu diesem Datum kommt die Hype von Augrid !
Darauf lassen Sie sich festnageln !.
Herr Joelu die Hype ist nicht gekommen ! im Gegenteil Augridkurs bei 0,003 Euro !
Herr Joelu Sie werden in diesem Thread absofort nicht mehr für ERNST genommen.

 

7 Reasons why HIV is the HIV testing company that will win in the end

1. Magic Johnson is contracted to help brand Calypte
Magic Johnson is one of the most successful businessmen of our time..with strong ties to the media
2. Scientists are running the company with strong ties to WHO and CDC
3. Luc Montagnier who discovered HIV 1 is affiliated with the company another strong tie to CDC
4. They have the only FDA approved Urine Based Test..
Urine will be the choice among Africian natives who do not want ###### or swabs performed
5. They have the best marketing,packaging and name with the AWARE(tm) brand of HIV tests
6. the market for other STD tests is larger and they already have urine based tests ready to hit the market soon after theri HIV takes hold
7. Certain company executives are former Orasure employees
utilizing their contacts to move Calypte forward
 

die gleiche art und weise geantwortet wie kade. aber klar bei dem ist es ok, bei mir ist es lächerlich.

desweiteren: selbst, wenn ich den hype richtig vorhergesagt hätte, hättest du mir gesagt: alles glücksache.

aber ich bleibe dabei, du kind: der hype wird noch kommen und zwar dann, wenn keiner damit rechnet. wir werden noch mal kurse um die 0,03$ sehen.

wenn du wissen willst, was lächerlich ist, dann lies dir mal deine permanenten ankündigungen über news und umsätze durch. durch erzählst immer wieder das gleiche hier, egal, wieviel aktien kommen, egal wie weit die aufträge noch weg sind.

du bist frei lucky, frei von jeglicher lernfähigkeit.  

mehr in diesen Thread. Sie haben Sich selber disqualifiziert mit Ihrer Prognose von Augrid.
Sparen sie sich Ihre Kommentare  

80 Mio neue Aktien proklamiert- wir sagten Dir hier das Gegegnteil. Wer hatte Recht ? Du mal wieder nicht ! Also schreib hier bitte nichts von ständigen neuen Aktien- es sei denn Du willst hier wissentlich falsche Infos verbreiten. Willst Du das ?

Muahahahahahaha a la Jölue

 

ich habe mit meiner langfristprognose bisher immer recht gehabt bei caly. langsamer, qualvoller abstieg!

da schadet mir auch eine fehlprognose mal nicht. was meinst du, wieviel neue aktien jetz im märz wieder angekündigt werden? muahahahahaha....vermischt mit guten testergebnissen, um ein abrutsche auf unter 0,20$ zu verhindern.

du könntest ja nochmal wetten. aber dazu hast du ja leider keinen arsch in der hose. dürfte doch ein leichtes sein, gegen so einen nichtsblicker wie mich die wette zu gewinnen, oder?

ich sage dir, noch im märz kommt die ankündigung über weitere neue aktien. und wer nicht hören will, der muß es spüren!!!